lobbying_activities: 3435780

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3435780	cd67c160-e3c1-41d9-ac72-6ca6566c57ae	Q3	TRAVERE THERAPEUTICS	401104190	TRAVERE THERAPEUTICS	2025	third_quarter	PHA	HR 946 and S. 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act); related provisions in H.R.1, One Big Beautiful Bill Act; Most Favored Nation and international reference pricing proposals	HOUSE OF REPRESENTATIVES,SENATE		110000	0	0	2025-10-16T10:12:56-04:00